Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial.
Ann Oncol. 2005 Mar;16(3):411-8. doi: 10.1093/annonc/mdi087. Epub 2005 Jan 19.
Ann Oncol. 2005.
PMID: 15659420
Free article.
Clinical Trial.
A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.
Selle F, Wittnebel S, Biron P, Gravis G, Roubaud G, Bui BN, Delva R, Bay JO, Fléchon A, Geoffrois L, Caty A, Soares DG, de Revel T, Fizazi K, Gligorov J, Micléa JM, Dubot C, Provent S, Temby I, Gaulet M, Horn E, Brindel I, Lotz JP.
Selle F, et al. Among authors: provent s.
Ann Oncol. 2014 Sep;25(9):1775-1782. doi: 10.1093/annonc/mdu198. Epub 2014 Jun 3.
Ann Oncol. 2014.
PMID: 24894084
Free article.
Clinical Trial.
Item in Clipboard
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study.
André T, Tournigand C, Rosmorduc O, Provent S, Maindrault-Goebel F, Avenin D, Selle F, Paye F, Hannoun L, Houry S, Gayet B, Lotz JP, de Gramont A, Louvet C; GERCOR Group.
André T, et al. Among authors: provent s.
Ann Oncol. 2004 Sep;15(9):1339-43. doi: 10.1093/annonc/mdh351.
Ann Oncol. 2004.
PMID: 15319238
Free article.
Clinical Trial.
Item in Clipboard
Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol.
Lotz JP, Pautier P, Selle F, Viens P, Fabbro M, Lokiec F, Viret F, Gligorov J, Gosse B, Provent S, Ribrag V, Micléa JM, Dosquet C, Goetschel A, Cailliot C, Lefèvre G, Genève J, Lhommé C; Groupe d' Intensification des traitements des Tumeurs Ovariennes (ITOV Group).
Lotz JP, et al. Among authors: provent s.
Bone Marrow Transplant. 2006 Apr;37(7):669-75. doi: 10.1038/sj.bmt.1705310.
Bone Marrow Transplant. 2006.
PMID: 16501591
Clinical Trial.
Item in Clipboard
Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer.
Selle F, Gligorov J, Richard S, Khalil A, Alexandre I, Avenin D, Provent S, Soares DG, Lotz JP.
Selle F, et al. Among authors: provent s.
Braz J Med Biol Res. 2015 Jan;48(1):13-24. doi: 10.1590/1414-431x20144214. Epub 2014 Nov 4.
Braz J Med Biol Res. 2015.
PMID: 25493378
Free PMC article.
Item in Clipboard
A Phase I Trial of High-Dose Chemotherapy Combining Topotecan plus Cyclophosphamide with Hematopoietic Stem Cell Transplantation for Ovarian Cancer: The ITOV 01bis Study.
Selle F, Pautier P, Lhommé C, Viens P, Fabbro M, Lokiec F, Gligorov J, Richard S, Provent S, Soares DG, Lotz JP.
Selle F, et al. Among authors: provent s.
Chemotherapy. 2016;61(1):15-22. doi: 10.1159/000440606. Epub 2015 Nov 4.
Chemotherapy. 2016.
PMID: 26528705
Free article.
Clinical Trial.
Item in Clipboard
In situ activity of gelatinases during Lewis lung carcinoma progression.
Tucker GC, Ferry G, Provent S, Atassi G.
Tucker GC, et al. Among authors: provent s.
Ann N Y Acad Sci. 1999 Jun 30;878:534-7. doi: 10.1111/j.1749-6632.1999.tb07719.x.
Ann N Y Acad Sci. 1999.
PMID: 10415765
No abstract available.
Item in Clipboard
Cite
Cite